Patent ID: 9545411
Date: 2017-01-17
CPC Classifications: A61K,A61P

Claim:
1. A method for treating a progesterone-dependent condition selected from the group consisting of endometriosis and pain associated therewith, adenomyosis, endometriomas of the ovary, dysmenorrhea, uterine fibroids, endometrial hyperproliferation, ovarian cancer, and cervical cancer in a female in need of such treatment comprising: (a) orally administering a composition comprising a selective progesterone receptor modulator (SPRM) to the female daily for a period beginning on day 16 to 28 of a first menstrual cycle and ending on day 11-25 of a subsequent second menstrual cycle; and (b) contemporaneously vaginally administering a composition comprising an SPRM to the female daily for period beginning on day 1-10 of the second menstrual cycle and continuing until a desired therapeutic effect is achieved.